Skip to content

Market capitalization at other companies

Alkermes logo
AlkermesALKS
$5.89B+9.7%
JAN
Janus Living JAN
$5.56B+43,568%

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Enterprise value$4.86B+242%
P/E18×
P/S3.5×+2.3×

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%

Returns & leverage

See full
Return on equity-117%
Debt / equity-3.5×
Current ratio0.9×0.0×

Where this comes from

Computed from the period-end share price: $3.72B.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's market capitalization?
Indivior Pharmaceuticals, Inc. (INDV) reported market capitalization of $3.72B in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's market capitalization changed year-over-year?
Indivior Pharmaceuticals, Inc. 's market capitalization increased by 212.8% year-over-year, from $1.19B to $3.72B.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's market capitalization?
Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's market capitalization has grown at a 47.9% compound annual growth rate (CAGR), from $2.05B to $4.49B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.